CVS, IRS Near Settlement in $402M Tax Lawsuit, Removing Financial Uncertainty
CVS sits 35% above its 52-week low of $58.35.
Summary
CVS Health and the Internal Revenue Service are reportedly nearing a settlement in a $402 million tax-refund lawsuit, according to the Wall Street Journal. The lawsuit, which dates back to tax years 2014-2017, concerned domestic-manufacturing deductions. While the specific terms of the agreement are not yet disclosed and require approval from IRS officials and the congressional Joint Committee on Taxation, this development is a positive step towards resolving a long-standing legal and financial overhang for the company. A settlement would remove uncertainty and could result in a material tax refund for CVS, improving its financial clarity. Investors will watch for the final terms and approvals of the settlement.
At the time of this announcement, CVS was trading at $78.71 on NYSE in the Trade & Services sector, with a market capitalization of approximately $100.3B. The 52-week trading range was $58.35 to $85.15. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.